Upregulated LINC00565 Accelerates Ovarian Cancer Progression by Targeting GAS6 [Corrigendum]
Gong M, Luo C, Meng H, et al. Upregulated LINC00565 accelerates ovarian cancer progression by targeting GAS6. OncoTargets Ther. 2019;12:10011–10022.
Upon reviewing the article, the authors noticed an error in Figure 5D on page 10019, it should be presented as follows: The authors confirm that all of the results and conclusions of the article remain unchanged. The authors apologize for this error.
Read the original article
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]